3rd Quarter - Termination

CAPITOL HEALTH GROUP, LLC for AMERISOURCEBERGEN CORPORATION

Firm
Client
Income
$10,000
Expenses
—
Terminated
Jul 31, 2012

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.733 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.89 - Withholding Tax Relief Act of 2011 S.164 - Withholding Tax Relief Act of 2011 H.R.1483 - Drug Safety Enhancement Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.1584 - Drug Safety and Accountability Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act H.R. 5651 - Food and Drug Administration Reform Act of 2012 S. 3187 - Food and Drug Administration Safety and Innovation Act

LobbyistCovered position, as disclosed
CHELSEA ARNONE Temporary Employee, Congressman Fred Upton
MICHAEL BROMBERG —
SHAWN COUGHLIN —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); SENATE; Executive Office of the President (EOP); Congressional Budget Office (CBO); Office of Management & Budget (OMB)

Bills named: H.R. 905 (112th), H.R. 5651 (112th), H.R. 2245 (112th), S. 3187 (112th), S. 164 (112th), S. 733 (112th), S. 1584 (112th), S. 296 (112th), H.R. 1483 (112th), S. 89 (112th), H.R. 3026 (112th)

Medicare/Medicaid MMM

H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.733 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.89 - Withholding Tax Relief Act of 2011 S.164 - Withholding Tax Relief Act of 2011 H.R.1483 - Drug Safety Enhancement Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.1584 - Drug Safety and Accountability Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act H.R. 5651 - Food and Drug Administration Reform Act of 2012 S. 3187 - Food and Drug Administration Safety and Innovation Act

LobbyistCovered position, as disclosed
CHELSEA ARNONE Temporary Employee, Congressman Fred Upton
MICHAEL BROMBERG —
SHAWN COUGHLIN —

Contacted: Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Executive Office of the President (EOP); Office of Management & Budget (OMB); SENATE

Bills named: H.R. 905 (112th), S. 1584 (112th), S. 296 (112th), S. 164 (112th), S. 733 (112th), S. 89 (112th), S. 3187 (112th), H.R. 1483 (112th), H.R. 2245 (112th), H.R. 3026 (112th), H.R. 5651 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.